Stock Price
1.41
Daily Change
-0.07 -4.73%
Monthly
11.02%
Yearly
0%
Q2 Forecast
1.42

Autolus Therapeutics Ltd reported $25.33M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AstraZeneca USD -204M 3.48B Mar/2026
Autolus Therapeutics Ltd USD 25.33M 3.31M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Silence Therapeutics USD 12K 52K Dec/2025